Literature DB >> 21688103

Neuroleptic malignant syndrome with metoclopramide overdose coexisting with Clostridium difficile diarrhea.

Azhar Supariwala, Gunjan Kant, Raymonde E Jean.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21688103     DOI： 10.1007/s00134-011-2250-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  17 in total

1.  Neuroleptic malignant syndrome in the critical care unit.

Authors:  Stanley N Caroff; Henry Rosenberg; Stephan C Mann; E Cabrina Campbell; Kenneth A Sullivan
Journal:  Crit Care Med       Date:  2002-11       Impact factor: 7.598

2.  Risk factors for neuroleptic malignant syndrome. A case-control study.

Authors:  P E Keck; H G Pope; B M Cohen; S L McElroy; A A Nierenberg
Journal:  Arch Gen Psychiatry       Date:  1989-10

3.  The neuroleptic malignant syndrome manifested as a prolonged confusional state.

Authors:  T Van Putten; M Beckson; S R Marder
Journal:  J Clin Psychopharmacol       Date:  1988-06       Impact factor: 3.153

4.  Neuroleptic-induced extrapyramidal symptoms with fever. Heterogeneity of the 'neuroleptic malignant syndrome'.

Authors:  D F Levinson; G M Simpson
Journal:  Arch Gen Psychiatry       Date:  1986-09

5.  Neuroleptic malignant syndrome associated with metoclopramide.

Authors:  M B Robinson; R P Kennett; A E Harding; N J Legg; B Clarke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

6.  Case-control study of neuroleptic malignant syndrome.

Authors:  P Sachdev; C Mason; D Hadzi-Pavlovic
Journal:  Am J Psychiatry       Date:  1997-08       Impact factor: 18.112

7.  Diagnostic uncertainty in a case of neuroleptic malignant syndrome.

Authors:  Dallas P Seitz
Journal:  CJEM       Date:  2005-07       Impact factor: 2.410

Review 8.  Mortality from neuroleptic malignant syndrome.

Authors:  A Shalev; H Hermesh; H Munitz
Journal:  J Clin Psychiatry       Date:  1989-01       Impact factor: 4.384

9.  A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis.

Authors:  Nathan I Shapiro; Stephen Trzeciak; Judd E Hollander; Robert Birkhahn; Ronny Otero; Tiffany M Osborn; Eugene Moretti; H Bryant Nguyen; Kyle J Gunnerson; David Milzman; David F Gaieski; Munish Goyal; Charles B Cairns; Long Ngo; Emanuel P Rivers
Journal:  Crit Care Med       Date:  2009-01       Impact factor: 7.598

Review 10.  Neuroleptic malignant syndrome presenting without fever: case report and review of the literature.

Authors:  R Lev; R F Clark
Journal:  J Emerg Med       Date:  1994 Jan-Feb       Impact factor: 1.484
View more
  2 in total

1.  Neuroleptic Malignant Syndrome Associated with Lithium Toxicity.

Authors:  Vaibhav Patil; Rishab Gupta; Rohit Verma; Yatan Pal Singh Balhara
Journal:  Oman Med J       Date:  2016-07

2.  Elevated creatine kinase does not necessarily correspond temporally with onset of muscle rigidity in neuroleptic malignant syndrome: a report of two cases.

Authors:  Koichi Nisijima
Journal:  Neuropsychiatr Dis Treat       Date:  2012-12-13       Impact factor: 2.570
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.